4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0000899243-21-000219
Chief Business Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2020-12-30 | Option exercise | +3,500 | $2.08 | $7,280 | 120,746 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2020-12-30 | Option exercise · Stock Option (right to buy) | −3,500 | 17,479 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…